Cajon Blvd, San Bernardino, CA 92407, USA Review counts shown on landing page: 10,978 and 10,257 (inconsistent, both brand-reported) Regulatory category: marketed as a dietary supplement
With an estimated 15 million Americans currently using GLP-1s and the market projected to reach $100 billion annually, understanding post-treatment outcomes has major implications for patients, prescribers, and payers alike
Feedback requested on coa/documentation visibility
This is a general risk during any significant weight lossnot specific to GLP-1s
In this crowded and often confusing landscape, finding a solution that is both effective and safe can feel like searching for a needle in a haystack
All such nutrients and dietary interventions can be ingested through food staples and supplements